# RPE Characterisation With Transscleral Optical Phase Imaging in Retinal Disorders

> **NCT04912622** · NA · COMPLETED · sponsor: **Luzerner Kantonsspital** · enrollment: 210 (actual)

## Conditions studied

- Retinal Disease
- Eye Disease

## Interventions

- **DIAGNOSTIC_TEST:** Clinical Trial

## Key facts

- **NCT ID:** NCT04912622
- **Lead sponsor:** Luzerner Kantonsspital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-19
- **Primary completion:** 2022-10-31
- **Final completion:** 2022-10-31
- **Target enrollment:** 210 (ACTUAL)
- **Last updated:** 2023-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04912622

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04912622, "RPE Characterisation With Transscleral Optical Phase Imaging in Retinal Disorders". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04912622. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*